[HTML][HTML] Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants

…, AA Amoako, A Rooker, C Cognigni… - Nature …, 2023 - nature.com
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…

Intrahost evolution and forward transmission of a novel SARS-CoV-2 Omicron BA. 1 subvariant

…, JMC Quiroz, A Amoako, A Rooker, C Cognigni… - 2022 - pesquisa.bvsalud.org
… Gonzalez-Reiche; Hala Alshammary; Sarah Schaefer; Gopi Patel; Jose Polanco; Juan
Manuel Carreno Quiroz; Angela Amoako; Aria Rooker; Christian Cognigni; Daniel Floda; …

SARS-CoV-2 spike-binding antibody longevity and protection from reinfection with antigenically similar SARS-CoV-2 variants

…, GY Cai, RL Chernet, C Cognigni… - MBio, 2022 - Am Soc Microbiol
The PARIS (Protection Associated with Rapid Immunity to SARS-CoV-2) cohort follows health
care workers with and without documented coronavirus disease 2019 (COVID-19) since …

[PDF][PDF] SARS-CoV-2-infection-and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

…, KF Beach, D Bielak, GY Cai, RL Chernet, C Cognigni… - Immunity, 2024 - cell.com
It is thought that mRNA-based vaccine-induced immunity to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) wanes quickly, based mostly on short-term studies. Here, …

[HTML][HTML] SARS-CoV-2 BA. 1 and BA. 2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ. 1.1 or XBB. 1.5

…, D Bielak, G Cai, C Cognigni… - Cell Reports …, 2024 - cell.com
Subvariants of the Omicron lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
efficiently escape neutralizing antibody responses induced by both vaccination …

[HTML][HTML] Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma

…, AK Zajdman, K Srivastava, C Cognigni… - Ebiomedicine, 2023 - thelancet.com
Background The real-world impact of bivalent vaccines for wild type (WA.1) and Omicron
variant (BA.5) is largely unknown in immunocompromised patients with Multiple Myeloma (MM)…

SARS-CoV-2 variants in the making: Sequential intrahost evolution and forward transmissions in the context of persistent infections

…, JM Carreño, AA Amoako, A Rooker, C Cognigni… - medRxiv, 2022 - medrxiv.org
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…

Intrahost evolution and forward transmission of a novel SARS-CoV-2 Omicron BA. 1 subvariant (preprint)

…, G Patel, J Polanco, A Amoako, A Rooker, C Cognigni… - 2022 - pesquisa.bvsalud.org
AO_SCPLOWBSTRACTC_SCPLOWPersistent SARS-CoV-2 infections have been reported
in immune-compromised individuals and people undergoing immune-modulatory treatments…

Bivalent COVID-19 booster vaccines induce cross-reactive but not BA. 5-specific antibodies in polyclonal serum

JM Carreño, G Singh, A Abbad, T Yellin, K Srivastava… - medRxiv, 2023 - medrxiv.org
The question if the bivalent mRNA COVID-19 booster vaccination, containing wild type and
BA.5 spike, provides enhanced benefits against BA.5 and similar Omicron subvariants has …

The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera

G Singh, A Abbad, G Kleiner, K Srivastava, C Gleason… - MBio, 2024 - Am Soc Microbiol
The Orthocoronavirinae subfamily is large comprising four highly divergent genera. Four
seasonal coronaviruses were circulating in humans prior to the coronavirus disease 2019 …